Does Markedly Elevated ALT Correlate with the Presence of Steatohepatitis or Advanced Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease?

被引:0
|
作者
Calo, Delia [1 ]
Gambarin-Gelwan, Maya [1 ]
Cavell, Lianne [1 ]
Edlin, Brian [1 ]
Duddempudi, Anupama [2 ]
Jacobson, Ira [1 ]
机构
[1] Weill Cornell Med Coll, New York, NY USA
[2] Scott & White Mem Hosp & Clin, Texas A&M Hlth Sci Ctr, Temple, TX 76508 USA
来源
关键词
D O I
10.14309/00000434-200910003-00401
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
401
引用
收藏
页码:S150 / S151
页数:2
相关论文
共 50 条
  • [1] Predictive Value of ALT for Diagnosing Non-Alcoholic Steatohepatitis (NASH) and Advanced Fibrosis in Patients With Non-Alcoholic Fatty Liver Disease (NAFLD)
    Verma, Siddharth
    Sharma, Prashant
    Hart, John
    Mohanty, Smruti R.
    GASTROENTEROLOGY, 2012, 142 (05) : S1019 - S1020
  • [2] Predictive value of ALT levels for non-alcoholic steatohepatitis (NASH) and advanced fibrosis in non-alcoholic fatty liver disease (NAFLD)
    Verma, Siddharth
    Jensen, Donald
    Hart, John
    Mohanty, Smruti R.
    LIVER INTERNATIONAL, 2013, 33 (09) : 1398 - 1405
  • [3] Predictors of Steatohepatitis and Advanced Fibrosis in Non-Alcoholic Fatty Liver Disease
    Pagadala, Mangesh
    Zein, Claudia O.
    McCullough, Arthur J.
    CLINICS IN LIVER DISEASE, 2009, 13 (04) : 591 - +
  • [4] Portal lymphadenopathy predicts non-alcoholic steatohepatitis and advanced fibrosis in non-alcoholic fatty liver disease
    Daher, Saleh
    Cohen, Namma Lev
    Massarwa, Muhammad
    Mahamid, Mahmud
    Nasser, Mira
    Hazou, Wadi
    Oren, Rani
    Safadi, Rifaat
    Khoury, Tawfik
    PLOS ONE, 2018, 13 (11):
  • [5] Factors predicting non-alcoholic steatohepatitis (NASH) and advanced fibrosis in patients with non-alcoholic fatty liver disease (NAFLD)
    Tasneem, Abbas Ali
    Luck, Nasir Hassan
    Majid, Zain
    TROPICAL DOCTOR, 2018, 48 (02) : 107 - 112
  • [6] The Serum Biomarkers of Cardiovascular Disease Are Elevated in Patients With Non-alcoholic Fatty Liver Disease (NAFLD) With Advanced Fibrosis and Histologically-Proven Non-alcoholic Steatohepatitis (NASH)
    Elsheikh, Elzafir
    Tran, Henry A.
    Karrar, Azza
    Estep, Michael
    Felix, Sean C.
    Jeffers, Thomas
    Younoszai, Zahra
    Racila, Andrei
    Fang, Yun
    Elsheikh, Munkhzul
    Lam, Brian P.
    Abdul-Al, Hala
    Goodman, Zachary
    Gerber, Lynn
    Younossi, Zobair M.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S538 - S539
  • [7] Predictors of non-alcoholic steatohepatitis and fibrosis in non-alcoholic fatty liver disease.
    Pong, JP
    Elariny, H
    Younoszai, A
    HEPATOLOGY, 2002, 36 (04) : 407A - 407A
  • [8] Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in patients with HIV
    Verna, Elizabeth C.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2017, 2 (03): : 211 - 223
  • [9] Is elevated aminotransferase levels a prerequisite to suspect non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease?
    Amin, M. A.
    Gabr, H. M.
    EL-Hindawy, A.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S191 - S192
  • [10] Independent Predictors of Non-alcoholic Steatohepatitis (NASH) and Advanced Fibrosis in a Large Cohort of Patients with Non-alcoholic Fatty Liver Disease (NAFLD)
    Fang, Yun
    Rafiq, Nila
    Afendy, Mariam
    Younossi, Youssef
    Lam, Brian
    Goodman, Zachary
    Younossi, Zobair
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2011, 106 : S120 - S120